Table 1

%hTR and hTERT in serum and tumor with clinical data concerning 18 breast cancer patients and 2 patients with benign breast disease

Patient no.AgeTypeapTNMhTRhTERT
TbSTS
168IDCpT4G2N0++NA
248IDCpT1cG2N0+ +
362IDCpT1cG1N0++
454IDCpT1bG2N0+ + +NA
576IDCpT2G3N1biii+ + +
671ILCpT2G2N0+ + +
769IDCpT1cG1N0+ + + +
859ILCpT2G1N0++
973IDCpT1cG1N0++
1056IDCpT2G2N1biii++ +
1161ILCpT2G2N1bii+
1267IDCpT1bG3N0+ + +
1386IDCpT2G3N0++
1487IDCpT4bG2N0++ +
1567IDCpT1bG1N0++
1657IDCpT1cG2N0++
1776BDNANA
1878PCISpT1cG3Nx++
1947IDCpT2G3Nbi++
2047BDNANA
  • a IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; PCIS, papilloma carcinoma in situ; BD, benign disease.

  • b T, tumor; S, serum; NA, not available.